Quince Therapeutics, Inc. (QNCX)
1.225
-0.02
(-2.00%)
USD |
NASDAQ |
Apr 15, 16:00
1.20
-0.02
(-2.04%)
After-Hours: 20:00
Quince Therapeutics Research and Development Expense (Annual) : 35.38M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Recursion Pharmaceuticals, Inc. | 425.27M |
| Ocular Therapeutix, Inc. | 197.10M |
| Gossamer Bio, Inc. | 174.07M |
| Ernexa Therapeutics, Inc. | 4.156M |
| Acurx Pharmaceuticals, Inc. | 1.834M |